一般磁疗和低频静电场的有效性:随机对照试验

封面


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

背景。目前乳腺癌患者康复过程中已提出多种物理治疗方法。然而,肿瘤康复的关键问题在于,现行模式尚未充分考虑联合治疗过程中产生的功能障碍。而减轻根治性治疗带来的不良反应和并发症,应有助于受损组织、器官及系统功能的恢复。

目的。探讨全身磁疗与低频交变静电场的作用机制,并论证其在乳腺癌术后第2至第4天起始应用及贯穿两个连续医学康复阶段中的有效性与合理性。

材料与方法。研究共纳入78例接受手术治疗的乳腺癌患者,病理分期为ⅡB期(T2N1M0, T3N0M0)和ⅢA期(T3N1M0,T1–2N2M0)。采用简单随机法将患者分为试验组和对照组,两个组在年龄及临床与功能指标方面均具有可比性,唯一区别在于两阶段康复过程中所采用的物理治疗方法不同。

结果。研究发现,在术后早期(第2–4天)和术后1–1.5个月分别实施两个阶段的医学康复,可有效减轻疼痛症状及术后水肿,提升患侧肩关节活动范围,预防严重淋巴水肿的发生,并改善生活质量。激光多普勒血流监测与肩部肌电图等临床功能评估结果进一步验证了上述效果。试验组患者的患侧肩关节活动范围恢复情况更佳。

结论。全身磁疗可通过选择性调节下丘脑及大脑皮层与皮层下结构的兴奋性,从而改善自主神经系统功能与心理情绪状态。低频交变静电场可有效减少蛋白性水肿的形成,恢复神经-肌肉系统的电兴奋性,提升组织弹性与功能状态,促进局部血流动力与微循环的改善。

全文:

受限制的访问

作者简介

Marina Y. Gerasimenko

Russian Medical Academy of Continuous Professional Education; N.I. Pirogov Russian National Research Medical University

Email: mgerasimenko@list.ru
ORCID iD: 0000-0002-1741-7246
SPIN 代码: 7625-6452

MD, Dr. Sci. (Medicine), professor

俄罗斯联邦, Moscow; Moscow

Irina V. Poddubnaya

Russian Medical Academy of Continuous Professional Education

Email: poddybnayiv@rmapo.ru
ORCID iD: 0000-0002-0995-1801
SPIN 代码: 1146-9889

MD, Dr. Sci. (Medicine), Professor, Аcademician of the Russian Academy of Sciences

俄罗斯联邦, Moscow

Inna S. Evstigneeva

Russian Medical Academy of Continuous Professional Education

编辑信件的主要联系方式.
Email: evstigneevais@mail.ru
ORCID iD: 0000-0001-9128-0965
SPIN 代码: 5163-7726

MD, Cand. Sci. (Medicine), Assistant Professor

俄罗斯联邦, Moscow

参考

  1. Kaprin AD, Starinsky VV, Petrova GV, editors. Malignant neoplasms in Russia in 2020 (incidence and mortality). Moscow: P.A. Herzen Medical Research Institute of Obstetrics and Gynecology — branch of the Federal State Budgetary Institution “NMIRC”; 2021. 250 p. (In Russ.)
  2. Gui Y, Liu X, Chen X, et al. A Network Meta-Analysis of Surgical Treatment in Patients With Early Breast Cancer. J Natl Cancer Inst. 2019;111(9):903–915. doi: 10.1093/jnci/djz105
  3. Gerasimenko MYu. The results of and prospects for the further development of medical rehabilitation and medical rehabilitation. Russian journal of physiotherapy, balneology and rehabilitation. 2017;16(1):4–5. doi: 10.18821/1681-3456-2017-16-1-4-5UDK EDN: YHMDBH
  4. Zhukova LG, Andreeva YuYu, Zvalishina LA, et al. Breast cancer. Clinical guidelines. 2021. (In Russ.) Available from: https://oncology-association.ru/files/clinical-guidelines-2021/Rak_molochnoj_zhelezy.pdf
  5. Kizhaev EV, Borisov VI, Vavilov MP, Kizhaev YuE. Breast cancer: diagnostics, treatment, rehabilitation. Scientific monograph. Moscow: FGBOU DPO RMANPO MH RF; 2020. (In Russ.)
  6. Fares J, Kanojia D, Rashidi A, et al. Diagnostic Clinical Trials in Breast Cancer Brain Metastases: Barriers and Innovations. Clin Breast Cancer. 2019;19(6):383–391. doi: 10.1016/j.clbc.2019.05.018
  7. Barco I, Chabrera C, García-Fernández A, et al. Role of axillary ultrasound, magnetic resonance imaging, and ultrasound-guided fine-needle aspiration biopsy in the preoperative triage of breast cancer patients. Clin Transl Oncol. 2017;19(6):704–710. doi: 10.1007/s12094-016-1589-7 EDN: KDQSIJ
  8. Bevers BT, Niel LB, Baker LJ, et al. NCCN Guidelines Insights: Breast cancer screening and diagnosis, Version 1.2023. National Comprehensive Cancer Network. 2023;21(9):900–909. doi: 10.6004/jnccn.2023.0046
  9. Dotan E, Walter CL, Broner IS, et al. NCCN Guidelines Insights: Older adult oncology, Version 1.2021. National Comprehensive Cancer Network. 2021;19(9):1006–1019. doi: 10.6004/jnccn.2021.0043
  10. Coelho RC, Da Silva FML, Do Carmo IML, Bonaccorsi BV, Hahn SM, Faroni LD. Is there a role for salvage radiotherapy in locally advanced breast cancer refractory to neoadjuvant chemotherapy? Breast. 2017;31:192–196. doi: 10.1016/j.breast.2016.10.026
  11. Wang GL, Tsikouras P, Zuo HQ, Huang MQ, Peng L, Bothou A, Zervoudis S, Tobias Teichmann A. Radioactive seed localization and wire guided localization in breast cancer: A systematic review and meta-analysis. J BUON. 2019;24(1):48–60.

补充文件

附件文件
动作
1. JATS XML
2. Fig. 1. Decrease in daily volume of a lymphorrhea at patients during the early postoperative period. * significant differences (p <0.05) between the indicators in the main and control groups.

下载 (103KB)
3. Fig. 2. Indicators of level of fibrinogen, g/l.

下载 (74KB)
4. Fig. 3. Indicators of level of thrombin time.

下载 (74KB)

版权所有 © Eco-Vector, 2025



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 86508 от 11.12.2023
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ЭЛ № ФС 77 - 80650 от 15.03.2021
г.